Terremoto Biosciences
About:
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Website: https://terremotobio.com
Top Investors: OrbiMed, Novo Holdings, Third Rock Ventures, EcoR1 Capital, Cormorant Capital
Description:
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Total Funding Amount:
$250M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2021-01-01
Founders:
Jack Taunton, Matthew Jacobson, Peter Thompson
Number of Employees:
11-50
Last Funding Date:
2023-11-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai